Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Guess what??? CDFT has a new BOD member and this is the latest news:
Now, a new player has stepped forward: DSCR and they are offering a 9.13.2013 deadline for shareholders of record to qualify for Anti-Dilutive Convertible Preferred Shares.
There are 2 companies that have already issued Anti-Dilutive Convertible Preferred Shares in addition to CDFT:
ANDI + ARNH
CDFT now building a legal team... Registration is drawing near...
CDFT is now getting ready to register their shares with a conversion in progress...
CDFT is an example of being debt-free and leaving the otcMarkets for the NYSE AlterNext...
Stand aside... No sense catching a falling knife...
Gold was down the most today. Could fall even more. Not sure what to do.
Getting a facelift... much needed and well deserved...
Thanks for leaving a message...
Lots of green for 2013. These charts are great!
Poll finds Americans angry about pretty much everything
http://news.yahoo.com/s/dailycaller/20110605/pl_dailycaller/pollfindsamericansangryaboutprettymucheverything;_ylt=AvDL0w.7kDMyZWL.GJ6KDSwuQE4F;_ylu=X3oDMTRsNzU0N2E2BGFzc2V0A2RhaWx5Y2FsbGVyLzIwMTEwNjA1L3BvbGxmaW5kc2FtZXJpY2Fuc2FuZ3J5YWJvdXRwcmV0dHltdWNoZXZlcnl0aGluZwRjY29kZQN0b3BnbXB0b3AyMDBwb29sBGNwb3MDMTAEcG9zAzEwBHNlYwN5bl90b3Bfc3RvcmllcwRzbGsDcG9sbGZpbmRzYW1l
Sun Jun 5, 11:25 am ET
No wonder David Bowie was afraid of Americans.
A new Newsweek/Daily Beast poll finds that Americans are angry about…pretty much everything. From President Obama to congressional Republicans to even God (who has a 33 percent approval rating), everyone needs to watch out for an angry mob coming their way.
Unemployment is at 9.1 percent, gas and grocery prices are skyrocketing, the housing market is in the dumps, and people aren’t happy. Three quarters of Americans think the country is on the wrong track, and 81 percent say the job market is not where it needs to be. Half of respondents don’t think Obama has a plan to balance the budget, and 58 percent think Republicans aren’t doing their part to balance the budget either.
The poll finds that Americans are being affected by their anger in other parts of life as well. Fifty-six percent are so angry that they can’t even sleep and 13 percent say the anxiety has affected their sex life. Twenty-six percent of married respondents claim the country’s economic problems have affected their marriage, with more than half of those people saying it has made their marriage worse.
11.1 Million U.S. Properties with Negative Equity in Q4
http://www.calculatedriskblog.com/2011/03/corelogic-111-million-us-properties.html
Mexican Central Bank Quietly Buys 100 Tons of Gold
http://www.globalresearch.ca/index.php?context=viewArticle&code=FAR20110505&articleId=24655
9 Health Care Stocks With 100% Buy Ratings
http://www.thestreet.com/_yahoo/story/11107715/1/9-health-care-stocks-with-100-buy-ratings.html
PATH $8.07 NuPathe - NuPathe Named Emerging Life Sciences Company of the Year
Company Honored at Greater Philadelphia's 2011 Enterprise Awards
http://finance.yahoo.com/news/NuPathe-Named-Emerging-Life-iw-3700473819.html?x=0&.v=1
Weekly Unemployment Claims Soar to 474,000
http://globaleconomicanalysis.blogspot.com/2011/05/weekly-unemployment-claims-soar-to.html
OT: Security Video Shows Man Struck by Lightning… TWICE
Osama Bin Laden Dead - President Obama
Dollar Falls for 10th Consecutive Day as Risk Appetite Swells
http://www.businessweek.com/news/2011-05-02/dollar-falls-for-10th-consecutive-day-as-risk-appetite-swells.html
Silver futures plunge most since 2008 as CME increases margins
http://economictimes.indiatimes.com/markets/commodities/silver-futures-plunge-most-since-2008-as-cme-increases-margins/articleshow/8145106.cms
PATH $8.73 NuPathe Announces Allowance of U.S. Patent Application for Its Migraine Patch
CONSHOHOCKEN, PA--(Marketwire - 05/02/11) - NuPathe Inc. (NASDAQ:PATH - News), a specialty pharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders, today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for U.S. patent application 12/181,142 entitled "Transdermal Methods and Systems for the Delivery of Anti-Migraine Compounds." This application relates to methods of effectively treating a migraine using an iontophoretic patch containing a triptan. Given this action, NuPathe expects the patent to issue within the next few months.
http://finance.yahoo.com/news/NuPathe-Announces-Allowance-iw-232940841.html?x=0&.v=1
Housing Crash 2.0 Is Accelerating
http://www.cnbc.com/id/42764835
Federal Reserve cuts forecasts for growth in the US
http://www.telegraph.co.uk/finance/economics/8478708/Federal-Reserve-cuts-forecasts-for-growth-in-the-US.html
McDonalds Hires 62,000, Turns Away Over 938,000 Applicants For Minimum Wage, Part-Time Jobs
http://www.zerohedge.com/article/mcdonalds-hires-62000-turns-away-over-938000-applicants-minimum-wage-part-time-jobs
More people requested unemployment benefits last week, the second increase in 3 weeks
http://finance.yahoo.com/news/More-people-applied-for-apf-1056781553.html
AFFY 6.67 - Affymax and Takeda Report Additional Phase 3 Clinical Trial Data for Peginesatide
http://finance.yahoo.com/news/Affymax-and-Takeda-Report-bw-660449909.html?x=0&.v=1
PATH 7.94 NuPathe Awaits FDA Decision for Migraine Skin Patch
http://seekingalpha.com/article/265882-nupathe-awaits-fda-decision-for-migraine-skin-patch
10 Health Care Stocks to Watch
http://www.thestreet.com/story/11096064/1/10-health-care-stocks-to-watch.html
IPCI 3.19 IntelliPharmaCeutics: CEO Speaks of Multiple Deals, FDA Catalysts in the Works
http://seekingalpha.com/article/265305-intellipharmaceutics-ceo-speaks-of-multiple-deals-fda-catalysts-in-the-works
LXRX 1.71 Lexicon Pharmaceuticals - 26-Apr-11 Initiated Wedbush Outperform $3
For the first time since the Great Depression, the US is now officially paying out more in benefits than it takes in via tax receipts.
http://www.zerohedge.com/article/it%E2%80%99s-game-over-us
The Few Companies Who Feed the World
Nestlé
Cereals
Cinnamon Toast Crunch
Cheerios (outside US, Canada and Australia)
Cini Minis
Honey Nut Cheerios (outside US, Canada and Australia)
Oat Cheerios
Cookie Crisp
Golden Grahams
Honey Stars
Koko Krunch
Milo Cereals
Nestlé Corn Flakes
Nesquik
Shreddies
Shredded Wheat
Clusters
Trix
Yogurt
Munch Bunch
Ski
Coffee
Bonka
Nescafé
Nespresso
Partner’s Blend
Ricoffy
Ristretto
Ricoré
Sical
Tofa
Taster’s Choice
Zoégas
Shrameet
Water
Aberfoyle
Aqua D’Or
Aqua Pod
Acqua Panna
Al Manhal
Aquapod
Arrowhead
Buxton
Contrex
Deer Park
Hépar
Ice Mountain
Henniez
Korpi
Levissima
Nestlé Aquarel
Nestlé Vera
Ozarka
Perrier
Poland Spring
Powwow
Minere
Pure Life/Pureza Vital
Quézac
San Pellegrino
San Bernardo
Viladrau
Vittel
Zephyrhills
Other drinks
Nestea (Joint venture with Coca-Cola, Beverage Partners Worldwide)
Enviga (Joint venture with Coca-Cola, Beverage Partners Worldwide)
Milo
Carnation
Caro
Nesquik
Libby’s
Growers Direct Organic Fruit Juices
Good Host
Juicy Juice
Ski up and go
Shelf-stable products
Bear Brand
Carnation
Christie
Coffee-Mate
Dancow
Gloria
Klim
La Lechera
Milkmaid
Nespray
Nestlé
Nesvita
Nestlé Omega Plus
Nido
Ninho
Svelty
Emswiss
Milo
Ice cream
Camy
Dreyer’s
Edy’s
Frisco
Häagen-Dazs (North America and the United Kingdom)
Hjem-IS (Denmark & Norway)
Maxibon
Motta
Mivvi
Nestlé
Nestlé Drumstick
Oreo (Canada)
Peters (Australia)
Push-Up
Schöller
Skinny Cow
Infant foods
Alete
Alfare
Beba
Cérélac
FM 85
Gerber (the world’s largest baby food company)
Good Start
Guigoz
Lactogen
Nan
NAN HA
NanSoy
Neslac
Nestlé
Nestogen
Nido
PreNan
Performance nutrition
Musashi
Neston
Nesvita
PowerBar
Pria
Supligen
Healthcare/nutrition
Boost
Carnation Instant Breakfast
Nutren
Peptamen
Glytrol
Crucial
Impact
Isosource
Fibersource
Diabetisource
Compleat
Optifast
Resource
Seasonings
Buitoni
Maggi
Carpathia
CHEF
Thomy
Winiary
Frozen foods
Stouffer’s
Lean Cuisine
Buitoni
Hot Pockets
Lean Pockets
Papa Guiseppi
Tombstone Pizza
Jack’s Pizza
DiGiorno Pizza
California Pizza Kitchen Frozen
Chocolate, confectioneries and baked goods
100 Grand Bar
Aero
After Eight
Allens
Animal Bar
Baby Ruth
Bertie Beetle (Australia)
Big Turk (Canada)
Black Magic
Boci (Hungary)
Blue Riband
Bono(Brazil)
Breakaway
Butterfinger
Butterfinger BB’s
Butterfinger Crisp
Bon Pari (Czech Republic, Poland and Hungary)
Cailler
Caramac
Carlos V
Chips Ahoy! (Canada)
Coffee Crisp
Chunky
Drifter
Frigor
Galak/Milkybar
Goobers
Heaven
Hercules Bars (with Disney)
Icebreakers
Kit Kat (Hershey’s in the US)
Lion
Matchmakers
Milky Bar
Mirage
Joff
Munchies
Nestlé Alpine White
Nestlé with Almonds
Nestlé Crunch
Nestlé Crunch Crisp
Nestlé Crunch with Caramel
Nestlé Crunch with Peanuts
Nestlé Crunch Pieces
Nestlé Crunch White
Nestlé Milk Chocolate
Nestlé Princessa
Nestlé Wonder Ball
Nips
Nuts (Europe)
Oh Henry (except US)
Peppermint Crisp
Perugina Baci
Polo
Quality Street
Raisinets
Rolo (Hershey’s in the US)
Rowntrees
Fruit Pastilles
Jelly Tots
Pick & Mix
Randoms
Fruit Gums
Tooty Frooties
Juicy Jellies
Snowcaps
Smarties
Texan Bar
Toffee Crisp
Toll House cookies
Turtles
Walnut Whip
Violet Crumble
Yorkie
XXX mints
Petcare
Alpo
Beneful
Cat Chow
Dog Chow
Fancy Feast
Felix
Friskies
Go Cat
Butchers
Bakers
Winalot
Gourmet
Mighty Dog
Mon Petit
ONE
Pro Plan
Purina
Tidy Cats
Kraft Foods
Toblerone chocolate bars
A1 Steak Sauce
Ali Coffee
Arrowroot biscuits
Back to Nature
Baker’s (chocolate)
Balance Bar
Better Cheddars
Boca Burger
Bonox
Breakstone’s
BullsEye Barbecue Sauce
Café HAG
California Pizza Kitchen (grocery store items)
Calumet Baking Powder
Cameo (biscuits)
Capri Sun (juice drink)
Carte Noire
Cheesybite
Cheese Nips
Cheez Whiz
Chicken in a Biskit
Chips Ahoy! (cookies)
Christie (Canadian division of Nabisco)
Claussen (pickles)
Clight
Club Social (crackers)
Cool Whip (non-dairy whipped cream)
CornNuts (snack food)
Côte d’Or (Belgium)
Country Time (powdered drink mix)
Cracker Barrel
Crystal Light
Dairylea (Europe)
Delissio (Canada)
DiGiorno (pizza)
Easy Cheese
Fig Newtons
Fudgee-O (Canada)
General Foods International
Grape-Nuts (breakfast cereal)
Grey Poupon (mustard)
Handi-Snacks
Honey Maid
In-A-Biskit (Australia)
Jack’s Pizza
Jacobs (Europe)
Jell-O (gelatin dessert)
Jet-Puffed Marshmallows
Kenco (United Kingdom)
Knox (gelatin)
Knudsen (dairy products)
Kool-Aid (flavored drink mix)
Kraft BBQ Sauce
Kraft Caramels
Kraft Macaroni and Cheese
Kraft Dinner (Canada)
Kraft Easymac
Kraft Mayo
Kraft Bagelfuls
Kraft Peanut Butter (Canada)
Kraft Singles (pasteurized prepared cheese product)
Kraft Sandwich Spread
Lefèvre-Utile
Lunchables
Maxwell House (coffee)
Miracle Whip (salad dressing spread)
Nabisco
Nabob (coffee) (Canada)
Naked Drinks
Nilla
Nutter Butter
Onko (coffee)
Oreo (cookie)
Oscar Mayer
Grated Parmesan cheese
Philadelphia cream cheese
Pigrolac
Planters
Polly-O (cheese)
Premium (a Nabisco brand of saltine crackers)
Pretzels
P’tit Québec
Prince Polo
Pure Kraft Salad Dressings
Ritz
Royal baking powder
Seven Seas (salad dressings)
Sanka (decaffeinated coffee)
Shake ‘n Bake
Simmenthal (canned meat)
Snackabouts
SnackWells
South Beach Living
Starbucks (grocery store items)
Stove Top stuffing
Suchard
Taco Bell (grocery store items)
Tang
Tassimo (single-serve coffee machines using pods branded as T-Discs)
PepsiCo
Drinks:
AMP
Brisk
Mountain Dew
Ocean Spray
Mist
Aquafina
Lipton Ice Tea
MUG
Pepsi
Sobe
Gatorade
Tropicana
No Fear Energy Drink
Propel Enhanced Water
Starbucks (retail products)
Food
Lay’s
Doritos
Tostitos
Cheetos
Fritos
Sun Chips
Baked!
Frito Lay Dips
Baken-Ets
Chester’s Puffcorn
Cracker Jack
El Isleno Plantain Chips
Frti-Lay Peanuts
Funyuns
Gamesa
Grandma’s
Matador
Maui Style Potato Chips
Miss Vickie’s
Munchies
Munchos
Natural
Nut Harvest
Quaker
Rold Gold
Ruffles
Sabritones
Santitas
Smartfood
Spitz
Stacy’s
Pizza Hut,
Taco Bell,
KFC,
Hot ‘n Now,
East Side Mario’s,
D’Angelo Sandwich Shops,
Chevys Fresh Mex,
California Pizza Kitchen
Stolichnaya.
Silver Surges to Record, But Inflation-Adjusted High Still Far Away
http://blogs.wsj.com/marketbeat/2011/04/25/silver-surges-to-record-but-inflation-adjusted-high-still-far-away
McDonald's warns of higher food inflation
http://finance.yahoo.com/news/McDonalds-warns-of-higher-rb-2533920012.html
Investments That Profit From Inflation
http://seekingalpha.com/article/264577-investments-that-profit-from-inflation
Big U.S. Firms Shift Hiring Abroad
Work Forces Shrink at Home, Sharpening Debate on Economic Impact of Globalization
http://online.wsj.com/article/SB10001424052748704821704576270783611823972.html
CEOs earn 343 times more than typical workers
http://money.cnn.com/2011/04/19/news/economy/ceo_pay/index.htm
The 10 Most Prescribed Drugs/The 10 Best-Selling Drugs
Hydrocodone (combined with acetaminophen) -- 131.2 million prescriptions
Generic Zocor (simvastatin), a cholesterol-lowering statin drug -- 94.1 million prescriptions
Lisinopril (brand names include Prinivil and Zestril), a blood pressure drug -- 87.4 million prescriptions
Generic Synthroid (levothyroxine sodium), synthetic thyroid hormone -- 70.5 million prescriptions
Generic Norvasc (amlodipine besylate), an angina/blood pressure drug -- 57.2 million prescriptions
Generic Prilosec (omeprazole), an antacid drug -- 53.4 million prescriptions (does not include over-the-counter sales)
Azithromycin (brand names include Z-Pak and Zithromax), an antibiotic -- 52.6 million prescriptions
Amoxicillin (various brand names), an antibiotic -- 52.3 million prescriptions
Generic Glucophage (metformin), a diabetes drug -- 48.3 million prescriptions
Hydrochlorothiazide (various brand names), a water pill used to lower blood pressure -- 47.8 million prescriptions.
The IMS reports that Americans spent $307 billion on prescription drugs in 2010.
The 10 drugs on which we spent the most were:
Lipitor, a cholesterol-lowering statin drug -- $7.2 billion
Nexium, an antacid drug -- $6.3 billion
Plavix, a blood thinner -- $6.1 billion
Advair Diskus, an asthma inhaler -- $4.7 billion
Abilify, an antipsychotic drug -- $4.6 billion
Seroquel, an antipsychotic drug -- $4.4 billion
Singulair, an oral asthma drug -- $4.1 billion
Crestor, a cholesterol-lowering statin drug -- $3.8 billion
Actos, a diabetes drug -- $3.5 billion
Epogen, an injectable anemia drug -- $3.3 billion
http://www.webmd.com/news/20110420/the-10-most-prescribed-drugs
IPCI 3.11 Intellipharmaceutics - Pipeline & Rexista
http://www.intellipharmaceutics.com/pipeline.cfm
Rexista™ (Oxycodone) "One of our key non-generic development products is Rexista™, an abuse- and alcohol-resistant, controlled-release oral oxycodone formulation. This product is covered by pending patent applications. Rexista™ is a unique dosage form, designed to be resistant to well-documented abuse that is experienced with current oxycodone products."
The pilot clinical trial produced the following results:
The Rexista™ product demonstrated sustained release pharmacokinetic activity, with blood plasma concentrations at clinically significant levels over a 24 hour period.
The bioavailability of a single dose of the Rexista™ product, as measured by Cmax and AUC, was comparable to that of two doses of Oxycontin® dosed at 12 hour intervals. Both Cmax and AUC were in the 80% - 125% range as compared to Oxycontin®, demonstrating effective bioequivalence with the branded product.
Due to the growing abuse associated with certain painkillers, in February 2009 the FDA announced that it plans to implement a Risk Evaluation and Mitigation Strategy (REMS) requirement for all extended-release opioid analgesics. The REMS plan is driving current R&D efforts and may ultimately drive prescribing of newer tamper-resistant extended-release opioids. We believe that the FDA's move to restrict prescribing of extended-release opioid analgesics should benefit tamper-resistant formulations such as Rexista™.
http://www.intellipharmaceutics.com/oxycodone.cfm
Re/Max CEO Margaret Kelly: We've Been Wrong Every Month For 5 Years, But Now Is REALLY The Time To Buy (Bloomberg Interview)
http://www.bloomberg.com/news/2011-04-20/u-s-existing-home-sales-rise-fail-to-recover-ground-lost.html
Jim Rogers on chances of $100+ Silver in 2011
America’s Most Popular Drugs
2010 1-year growth (%) 5-year growth (%)
Drug (brand name) use 3995.2 1.16% 7.79%
1 hydrocodone/acetaminophen (Vicodin) pain 131.2 2.34% 16.73%
2 simvastatin (Zocor) high cholesterol 94.1 12.29% 553.47%
3 lisinopril high blood pressure 87.4 5.56% 34.05%
4 levothyroxine sodium (Synthroid) hypothyroid 70.5 6.82% 41.57%
5 amlodipine besylate (Norvasc) high blood pressure. 57.2 11.50% NA
6 omeprazole (Prilosec) acid reflux 53.4 17.62% 196.67%
7 azithromycin (Zithromax) antibiotic 52.6 -2.23% 44.11%
8 amoxicillin antibiotic 52.3 -0.19% -4.39%
9 metformin HCL (Glucophage) diabetes 48.3 9.03% 25.78%
10 hydrochlorothiazide high blood pressure 47.8 -0.21% -0.42%
11 alprazolam (Xanax) anxiety 46.3 5.47% 23.14%
12 Lipitor (atorvastatin) high cholesterol 45.3 -12.38% -38.78%
13 furosemide high blood pressure 43.4 -0.23% -2.03%
14 metoprolol tartrate (Lopressor) high blood pressure
38.9 -5.35% 33.22%
15 zolpidem tartrate (Ambien) insomnia 38 8.26% NA
16 atenolol high blood pressure 36.3 -7.63% -21.26%
17 sertraline HCL (Zoloft) depression 35.7 4.39% 230.56%
18 metoprolol succinate (Toprol) blood pressure 33 22.68% 5400.00%
19 citalopram (Celexa) depression 32.1 18.45% 129.29%
20 warfarin sodium (Coumadin) blood thinner 32 1.27% 19.85%
21 oxycodone/acetaminophen pain 31.9 5.63% 39.91%
22 ibuprofen pain 31.1 2.64% 16.04%
23 Plavix (clopidogrel) heart disease 29.5 -1.34% 60.33%
24 gabapentin (Neurontin) 29.3 15.35% 58.38%
25 Singulair (montelukast) allergies
28.7 0.35% 2.14%
http://blogs.forbes.com/matthewherper/2011/04/19/americas-most-popular-drugs/
16 Small Caps With Cash to Cover 1+ Years of Operating Expenses
http://seekingalpha.com/article/264337-16-small-caps-with-cash-to-cover-1-years-of-operating-expenses
OSUR 8.58 OraSure Technologies - OraSure Technologies Earnings Conference Call Invitation
2011 First Quarter Earnings Conference Call Wednesday, May 4, 2011, 5:00 p.m. ET
BETHLEHEM, Pa., April 20, 2011 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR - News) has scheduled its regular earnings conference call covering 2011 first quarter financial results and certain 2011 financial guidance for 5:00 pm ET (2:00 pm PT) on Wednesday, May 4, 2011. An update on certain business developments will also be provided.
May 4, 2011 Schedule
4:00 p.m. ET 2011 first quarter financial results will be distributed by GlobeNewswire
4:50 p.m. ET
To participate in the conference call, dial 877-348-9357 (Domestic) or 970-315-0488
(International) and reference Conference ID #61775799.
5:00 p.m. ET Conference call and simultaneous Webcast begins
The conference call will also be webcast live and may be accessed on the Investor Relations page of OraSure's website, www.orasure.com. Please click on the webcast link and follow the prompts for registration and access 10 minutes prior to the call.
If you are unable to participate, a replay of the call will be archived on OraSure's website shortly after the call has ended and will be available for seven days. A replay of the call can also be accessed until midnight, May 11, 2011 by dialing 800-642-1687 (Domestic) or 706-645-9291 (International) and entering the Conference ID # 61775799.
http://finance.yahoo.com/news/OraSure-Technologies-Earnings-pz-424880102.html?x=0&.v=1
NYSE |
| NASDAQ |
DOW | S&P 500 | |
The link below is a collection of sector performance for 1 day, 1 week, 1 month, 3 months, 6 months, 1 year and year-to-date.
DISCLAIMER:
Opinions expressed on this board are just that. Opinions. We are not licensed brokers. Trading strategies discussed on this board are often high risk and not suitable everyone. If you are losing money in the market, you may wish to seek the advice of a licensed securities professional. No one is responsible for your gains or losses in the market except YOU. If you follow stocks, strategies discussed on this board, you may LOSE ALL YOUR MONEY. Please weigh the strategies discussed here carefully against what you are willing to risk. Please do your own due diligence before buying or selling ANY SECURITY in the open market, there are no guarantees. The moderators may or may not be in a stock mentioned on this message board. Make your own trading decisions...
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |